PainReform Ltd. (PRFX)
NASDAQ: PRFX · Real-Time Price · USD
1.160
-0.080 (-6.45%)
At close: Nov 3, 2025, 4:00 PM EST
1.160
0.00 (0.00%)
After-hours: Nov 3, 2025, 4:25 PM EST

PainReform Stock Forecast

Stock Price Forecast

There have not been any analyst price target forecasts for PainReform in the last 12 months.

Price Target: n/a
Analyst Consensus: n/a
TargetLowAverageMedianHigh
Pricen/an/an/an/a
Changen/an/an/an/a

Analyst Ratings

There are currently no analyst ratings available for PainReform.

Recommendation Trends

RatingAug '24Sep '24Oct '24
Strong Buy110
Buy000
Hold000
Sell000
Strong Sell000
Total110

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Maxim Group
Maxim Group
Hold
Downgrades
n/a
HoldDowngradesn/an/aOct 24, 2024
Maxim Group
Maxim Group
Strong Buy
Reiterates
$48
Strong BuyReiterates$48+4,037.93%Jun 26, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-49.20
from -32.16
EPS Next Year
-35.99
from -49.20
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
-------
Revenue Growth
-------
EPS
-299.87-174.00-63.46-63.13-32.16-49.20-35.99
EPS Growth
-------
Forward PE
-------
No. Analysts
-----33
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026
Highn/an/a
Avgn/an/a
Lown/an/a

Revenue Growth

Revenue Growth20252026
High--
Avg--
Low--

EPS Forecast

EPS20252026
High-50.65-37.04
Avg-49.20-35.99
Low-47.28-34.57

EPS Growth

EPS Growth20252026
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.